BUZZ - Global medical services company’s shares fall due to warning on Medicaid program impact
路透社2026/10/27 21:38October 27 - ** Universal Health Services (UHS.N) shares fell 5% in after-hours trading to $168.5
** UHS warned that changes to Medicaid programs could have a significant impact on its future operating results
** The company said the new Medicaid eligibility requirements are expected to reduce enrollment and spending, which will lower revenues and increase uncompensated care in its facilities
** The company said higher borrowing costs have led to increased interest expenses and reduced free cash flow; if interest rates rise further, this could adversely affect future performance and cash flow
** According to LSEG-compiled data, the company's adjusted earnings per share for the third quarter were $5.22, higher than analysts' expectations of $5.16
** The report said third-quarter revenue was $4.73 billion, above the expected $4.71 billion
** Additionally, larger peer HCA Healthcare (HCA.N) also said that due to reduced Medicaid payments and an increase in uninsured patients, its profits will be flat in 2027 ((link))
** UHS shares have fallen 18.6% year-to-date
(To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. As automated translation may contain errors or lack required context, Reuters does not guarantee the accuracy of this translated text, which is provided solely for reader convenience. Reuters accepts no liability for any damage or loss arising from the use of automated translation.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Bonds Could Become the Hedge Against AI Selloff as Correlation Turns Negative
JPMorgan lowered Boeing's target price to $240.
"For the first time in history" Annual Guidance Released in Advance! JPMorgan Maintains 'Overweight' Rating for ASM International (ASMIY.US), Earnings Outlook May Continue to Improve
JPMorgan maintains an Overweight rating on ASMI with a target price of 1,174 euros, stating that this is the first time the company has provided guidance for 2027. The outlook is highly visible, and profit expectations may be revised up by a low double-digit percentage.